AU2002247081A1 - Tools and methods for identifying ppar$g(d)-specific agonists and antagonists - Google Patents
Tools and methods for identifying ppar$g(d)-specific agonists and antagonistsInfo
- Publication number
- AU2002247081A1 AU2002247081A1 AU2002247081A AU2002247081A AU2002247081A1 AU 2002247081 A1 AU2002247081 A1 AU 2002247081A1 AU 2002247081 A AU2002247081 A AU 2002247081A AU 2002247081 A AU2002247081 A AU 2002247081A AU 2002247081 A1 AU2002247081 A1 AU 2002247081A1
- Authority
- AU
- Australia
- Prior art keywords
- antagonists
- tools
- methods
- specific agonists
- ppar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
- G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27141201P | 2001-02-27 | 2001-02-27 | |
US60/271,412 | 2001-02-27 | ||
PCT/US2002/003408 WO2002068386A2 (en) | 2001-02-27 | 2002-02-27 | Tools and methods for identifying ppar$g(d)-specific agonists and antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002247081A1 true AU2002247081A1 (en) | 2002-09-12 |
Family
ID=23035432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002247081A Abandoned AU2002247081A1 (en) | 2001-02-27 | 2002-02-27 | Tools and methods for identifying ppar$g(d)-specific agonists and antagonists |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002247081A1 (en) |
WO (1) | WO2002068386A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120099378A (en) * | 2009-08-14 | 2012-09-10 | 닛뽕 케미파 가부시키가이샤 | Use of ppar delta ligands for the treatment or prevention of inflammation or energy metabolism/production related diseases |
CN107050020A (en) | 2012-05-01 | 2017-08-18 | 特兰斯拉图姆医学公司 | Method for treating and diagnosing blinding illness in eye |
CN112168820B (en) * | 2019-07-05 | 2023-09-29 | 中国科学院生物物理研究所 | Application of SRCAP ATPase inhibitor in colorectal cancer treatment |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2360103A1 (en) * | 1999-02-08 | 2000-08-17 | Robert Sladek | Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding orphan nuclear receptor erralpha |
-
2002
- 2002-02-27 WO PCT/US2002/003408 patent/WO2002068386A2/en not_active Application Discontinuation
- 2002-02-27 AU AU2002247081A patent/AU2002247081A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002068386A3 (en) | 2004-02-19 |
WO2002068386A2 (en) | 2002-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003288917A1 (en) | Brazed diamond tools and methods for making the same | |
AU2001245305A1 (en) | System and method for an automated scoring tool for assessing new technologies | |
AU2002332565A1 (en) | Sample adapter | |
AU2002357833A1 (en) | System for identifying data relationships | |
AU2003265654A1 (en) | Tool holder and method | |
AU2003213123A1 (en) | Systems and methods for managing biological data and providing data interpretation tools | |
AU2003217846A1 (en) | Business analysis tool | |
AU2001238665A1 (en) | Method of identifying partial agonists of the a2a receptor | |
AU2001243182A1 (en) | Tool for analyzing corporate airline bids | |
AU2002361861A1 (en) | SELECTIVE 11Beta-HSD INHIBITORS AND METHODS FOR USE THEREOF | |
AU2001249754A1 (en) | Account management tool for e-billing system | |
AU2002231738A1 (en) | Drill/chamfer tool | |
AUPR645701A0 (en) | Database adapter | |
AU2002365703A1 (en) | Downhole tool retention apparatus | |
AU2003251958A1 (en) | Warranty managing process | |
AU3595800A (en) | Solid lubrication tools and methods for their production and use | |
AU2002247081A1 (en) | Tools and methods for identifying ppar$g(d)-specific agonists and antagonists | |
AU2002311994A1 (en) | Block corruption analysis and fixing tool | |
AU2002246912A1 (en) | Receptor-binding compounds and methods for identifying them | |
AU2002257911A1 (en) | Tool block | |
AU2003287450A1 (en) | Boron containing overbased calixarates, lubricants comprising the same and methods for there preparation | |
AU2001280916A1 (en) | Methods for identifying genomic deletions | |
AU2002358962A1 (en) | System and method for automatic gemstone polishing | |
AU2003292424A1 (en) | Tool holder | |
AU2002364929A1 (en) | Methods for identifying racemases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |